Related Experiment Video
Updated: Sep 24, 2025
08:31
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
5.2K
Xenobots: Applications in Drug Discovery.
Nilay Solanki1, Sagar Mahant1, Swayamprakash Patel2
1Department of Pharmacology, Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, CHARUSAT Campus, Changa, Gujarat, India.
Current Pharmaceutical Biotechnology
|May 4, 2022
Summary
Living xenobots, built from frog cells and AI, show promise in drug discovery and treating diseases like Alzheimer's and cancer. Their unique design and self-repairing abilities offer new therapeutic possibilities.
Area of Science:
- Biotechnology
- Artificial Intelligence
- Robotics
Background:
- Xenobots represent a novel class of living robots constructed from frog embryonic stem cells.
- Their creation merges expertise from biosciences, artificial intelligence, and computer science.
Approach:
- Designs are generated using artificial intelligence in in vitro and in silico models.
- Software analyzes and filters designs, with in vivo development in MMR solution replicating the selected forms.
- Xenobots are evaluated based on their behavior, movement, function, and inherent features.
Key Points:
- Xenobots are utilized in medical and pharmaceutical research for evaluating new drug delivery systems.
- Their self-repairing properties enable targeted drug delivery and reduced cytotoxicity in cancer treatment.
- Potential applications include treating neurodegenerative diseases like Alzheimer's and Parkinson's.
Conclusions:
- Xenobots offer a groundbreaking platform for drug discovery and targeted therapies.
- Future research aims to leverage xenobots for treating chronic illnesses and their complications.
Keywords:
Xenopus laevisbioengineeringin silicoin vivomedical researchpharmaceutical researchxenobotsMore Related Videos
Related Concept Videos
01:26Drug Discovery: Overview
8.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.9K
01:28Structure-Activity Relationships and Drug Design
1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
01:24Principles of Drug Action
6.8K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.8K
01:16Drug Biotransformation: Overview
3.0K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.0K
01:26Targets for Drug Action: Overview
7.6K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.6K
01:30Prodrugs
3.2K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
3.2K